Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$13.19 0.05 (0.38%)
2/9/2010 4:00 PM

China Medical Technologies, Inc. (ADR) (CMED)

CAPS Rating:
*****

A China-based medical device company that develops, manufactures & markets advanced in-vitro diagnostics products using Enhanced Chemiluminescence technology & Fluorescent in situ Hybridization technology, to detect & monitor various diseases & disorders.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating CMED

Add Stock to Watchlist

China Medical Technologies, Inc. (ADR) At A Glance

Current Price: $13.19
Last Trade Time: 2/9/2010 4:00 PM
Open: $0.00
Previous Close: $13.14
Daily Range: $13.12 - $13.54
52-Week Range: $11.41 - $26.07
Volume: 274,357
Market Cap: $423.49M
P/E Ratio: 7.05
Compare Our Special Broker Offers!

Stock Trends

CMED VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

1

China Medical Technologies, Inc. (ADR) (CMED)

Avatar riegonla (88.48) Submitted: 10/15/09 1:53 AM

28,6 US$ Feb 2010

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

China Medical Technologies, Inc. (ADR) (CMED)

Avatar beinthelight (< 20) Submitted: 9/21/09 5:23 PM

So what is the big deal about a $30M share buy back, this is less than 6% of the shares outstanding. If I understand it correctly, CMED has three main product lines, the ECLIA, FISH and SPR systems. The ECLIA system is one of the two main revenue and earnings product lines, the other being the FISH ...More

Replies: 2 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 205 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (CMED)

Avatar DavidSobel (38.25) Submitted: 2/01/10 7:04 PM : Outperform Start Price: $14.58 CMED Score: -3.90

A country that values gender specific children they should make a fortune

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CMED)

Avatar Voidd (< 20) Submitted: 1/28/10 10:52 AM : Outperform Start Price: $13.20 CMED Score: 1.49

Low price, good market, strong competitors but chinese may favor local firms.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CMED)

Avatar lola99999 (< 20) Submitted: 12/16/09 10:29 PM : Outperform Start Price: $14.05 CMED Score: -2.96

CMED

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CMED)

Avatar tctk1044 (72.53) Submitted: 12/14/09 3:36 PM : Outperform Start Price: $14.35 CMED Score: -3.99

Heavily discounted. With the share buy back this should bounce back pretty quickly. Although CMED may have posted a loss, it's still a great company for shareholders. Buying under $17 is good, buying under $15 is great.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CMED)

Avatar BradLSU (< 20) Submitted: 12/14/09 2:36 AM : Outperform Start Price: $14.77 CMED Score: -6.54

Stock price down from 52wk high of 26 per share. This is a riskier pick for me from the standpoint of the stock now having cash per share of stock to talk about. I also don't understand the technical details of what their diagnostics are. However, I will demonstrate that intuition, and noting other business factors will pay off.

Intuition: The macroeconomic activity for China is just beginning, every city is becoming more civilized, and more and more hospitals/doctor offices will reach more rural markets. Diagnostics are the forefront of all health care. The Chinese FDA approved 2 systems CMED uses one on 10/6/09 the other on 11/9/09. This tells me CMED is legit and has quality control.

Business Factors:
-Shareholder friendly company. $30 million share buyback was announced to take place over a year that began on 10/1/09 when the stock was at $15. I estimated this will reduce overall outstanding shares between 3-5%. This helps the company but making each share more valuable, in affect creating more earnings per share.
-If they are stable enough to shell out money for share buyback, this tells me the 3.60% dividend rate is stable for the medium term future.
-And then finally my favorite...4 different insiders have bought a combined $2,911,960 worth of stock since march 09' all about $13 per share, right below where they stock is now.

In summary this is a great opportunity even if one does not understand all the fine tuned details about the products they sell.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 205 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 5 of 5  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackMuhlenkamp 24.42 10/29/09 Outperform 1Y $15.25-13.51%+1.93%-15.44 Toggle the visibility of 60-Second Pitch and replies
TrackStandpoint 97.82 07/17/09 Outperform NS $18.88-30.12%+14.54%-44.66
TrackJimCramer < 20 01/06/09 Underperform 3W $19.74-33.18%+16.73%+49.91
TrackWayneRogers < 20 02/22/08 Outperform 3M $53.13-75.17%-17.61%-57.57
TrackBearStearns 84.85 11/21/07 Outperform NS $40.10-67.11%-21.49%-45.62

Results 1 - 5 of 5  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD02 296ms